期刊文献+

格列吡嗪合用二甲双胍对2型糖尿病患者的影响

Glipizide plus metformin for treating type 2 diabetes
下载PDF
导出
摘要 目的探讨格列吡嗪合用二甲双胍对2型糖尿病患者的影响。方法 2型糖尿病患者160例根据治疗药物应用的不同分为治疗组与对照组各80例,对照组采用二甲双胍治疗,治疗组在此基础上给予格列吡嗪治疗。结果两组治疗前FBG、2hBG值对比无明显差异,治疗后都有明显下降(P<0.05),同时组间对比差异明显(P<0.05)。两组治疗前LDL、TG、TC值对比差异无统计学意义,治疗后都有明显下降(P<0.05),同时组间对比差异明显(P<0.05)。结论格列吡嗪合用二甲双胍应用于2型糖尿病患者能有效降低血糖与血脂含量,值得推广应用。 Objective To investigate the effects of glipizide plus metformin for treating type 2 diabetes. Methods 160 cases with type 2 diabetes were equally divided into the treatment group and the control group, the control group were given metformin, the treatment group were added the glipizide. Results FBG, 2hBG, TG, TC, LDL values between the two groups before treatment contrasted had no significant difference, after treatment there were decreased significantly (P〈0.05) and contrasted the differences had significant (P〈0.05). Conclusion Glipizide plus metformin used in patients with type 2 diabetes can effectively decrease blood sugar and lipids that should be widely applied.
出处 《中国卫生产业》 2013年第15期22-23,共2页 China Health Industry
关键词 格列吡嗪 二甲双胍 2型糖尿病 血糖 血脂 Glipizide Metformin Type 2 diabetes Blood sugar Lipids
  • 相关文献

参考文献5

二级参考文献35

  • 1李延兵,廖志红,许雯,姚斌,邓婉萍,欧香忠,胡国亮,翁建平.胰岛素泵治疗对初诊2型糖尿病患者糖脂代谢的影响[J].中山大学学报(医学科学版),2004,25(4):359-363. 被引量:40
  • 2李延兵,朱慧丽,姚斌,黄知敏,欧香忠,肖亦斌,翁建平.短期持续皮下胰岛素输注治疗对初诊2型糖尿病疗效的影响因素分析[J].中华医学杂志,2005,85(9):602-605. 被引量:48
  • 3李延兵,刘娟,廖志红,廖瑛,邓婉萍,翁建平.速效胰岛素类似物和可溶性人胰岛素在初诊2型糖尿病胰岛素泵治疗中作用的比较[J].中华医学杂志,2005,85(35):2472-2476. 被引量:26
  • 4Chung M, Kourides I, Canovatchel W, et al. Pharmacokinetics and pharma - codynamics of extended- release glipizide GITScompared with immediate- release glipizide in patients with type Ⅱ diabetesmellitus. J Clin Pharmacol , 2002 ,42(6) :651.
  • 5中华人民共和国卫生部药政局.降糖药物临床研究指导原则 新药(西药)临床及临床前研究指导原则[M].,1993.82-85.
  • 6Berelowitz M, Fischette C, Cefalu W, et al. Comparative efficacy of a once - daily controlled - release formulation of glipizideand immediate - release glipizide in patients with NIDDM. Diabetes Care, 1994,17 (12):1460.
  • 7Piero OB, Lilach OL, Amir L, et al. Endothelial Dysfunction: A Marker of Atherosclerotic Risk. Arterioscler Thromb Vasc Biol,2003,23(1):168-175.
  • 8Report of WHO Consultation, Diagnosis and classification of diabetea mellitus. Genveva: WHO,1999,59p.
  • 9Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 1992,340:1111-1115.
  • 10Calles-Escandon J, Cipolla M. diabetes and endothelial dyfunction: a clinical perspective. Endocr Rev, 2001,22(1):36-52.

共引文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部